We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

Alternate Donor Study of Pre-Emptive Cellular Therapy (CMV-ACE/ASPECT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01220895
Recruitment Status : Completed
First Posted : October 14, 2010
Last Update Posted : January 25, 2018
Leukaemia Lymphoma Research
National Health Service, Blood and Transplant
University of Birmingham
Information provided by (Responsible Party):
Cell Medica Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2013
Actual Study Completion Date : January 2014